Immune switch PD-L1 works differently in cancer and flu (IMAGE)
Caption
While cancer therapies work by blocking PD-L1 to boost immune attack on tumors, new research suggests that enhancing PD-L1 signaling may help the body control severe respiratory viral infections.
Credit
The Jackson Laboratory
Usage Restrictions
none
License
Original content